Hyttinen Virva, Taipale Heidi, Tolppanen Anna-Maija, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa, Valtonen Hannu
1 University of Eastern Finland, Kuopio, Finland.
2 Karolinska Institutet, Stockholm, Sweden.
Ann Pharmacother. 2017 Sep;51(9):725-734. doi: 10.1177/1060028017708394. Epub 2017 May 9.
Potentially inappropriate medications (PIMs) increase the risk of adverse drug reactions and events and have been associated with greater health care service use, such as an increased risk of hospitalization.
The aim of this study is to evaluate the association between PIM use and hip fractures in a nationwide cohort of community-dwelling persons ≥65 years old with Alzheimer's disease (AD).
The study, which is based on the Finnish nationwide MEDALZ cohort, included all persons diagnosed with AD between 2005 and 2011 (n = 70 718). After a 1-year washout period for PIM use and exclusion of persons with previous hip fracture before AD diagnosis or those who had been hospitalized, we included 47 850 persons ≥65 years old with AD. PIM use was identified using Finnish criteria. Associations between PIM use and hip fracture were analyzed with Cox proportional hazards regression.
Of the study population, 12.3% (n = 5895) initiated PIMs during the follow-up (maximum follow-up 2921 days and total number of person-years 139 538.7). Of those, 103 (1.7%) persons had hip fractures during the PIM use period. The results suggest that PIM use was only associated with an increased risk of hip fracture with incident PIM use (adjusted hazard ratio = 1.31; 95% CI = 1.06-1.63; P = 0.014).
PIM use is associated with increased risk of hip fracture when a person uses PIMs for the first time. However, the association between PIM use and hip fracture should be investigated more comprehensively in future studies.
潜在不适当用药(PIMs)会增加药物不良反应和事件的风险,并与更多的医疗服务使用相关,例如住院风险增加。
本研究旨在评估≥65岁患有阿尔茨海默病(AD)的社区居住人群全国队列中PIMs使用与髋部骨折之间的关联。
该研究基于芬兰全国性的MEDALZ队列,纳入了2005年至2011年间所有被诊断为AD的患者(n = 70718)。在对PIMs使用情况进行1年的洗脱期,并排除AD诊断前有髋部骨折史或已住院的患者后,我们纳入了47850名≥65岁的AD患者。使用芬兰标准确定PIMs的使用情况。采用Cox比例风险回归分析PIMs使用与髋部骨折之间的关联。
在研究人群中,12.3%(n = 5895)在随访期间开始使用PIMs(最大随访2921天,总人年数为139538.7)。其中,103人(1.7%)在使用PIMs期间发生了髋部骨折。结果表明,仅首次使用PIMs与髋部骨折风险增加相关(调整后的风险比 = 1.31;95%置信区间 = 1.06 - 1.63;P = 0.014)。
首次使用PIMs时,PIMs使用与髋部骨折风险增加相关。然而,未来的研究应更全面地调查PIMs使用与髋部骨折之间的关联。